Equilibre
New York
About Equilibre
Equilibre is a biopharmaceuticals corporation developing differentiated and novel therapeutic candidates. Équilibre is founded upon advancing science to benefit patients. They are committed to delivering innovative treatments to millions of patients who experience conditions for which there are inadequate or nonexistent treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $52.4M
- Last round: Series Unknown (Dec 2022)
- Website: eqneuro.com
- Phone: (332) 400-0300
Industries & Categories
Biotechnology, Neuroscience, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/equilibre-6 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.